IMI launches 3rd Call for proposals
IMI has officially launched the 3rd Call for proposals on 22 October 2010.
The Call includes the following topics:
- Drug induced liver injury
- Immunogenicity of biopharmaceuticals
- Immunosafety of vaccines
- Patient awareness
Detailed descriptions of the 3rd Call topics and information and documents necessary for submitting an Expression of interest are available here.
Webinars on 3rd Call topics
In the next few weeks, the 3rd Call topics will be explained in detail during a series of webinars, each dedicated to one Call topic. The presentations will be given by the topic leaders and will the same as the ones given in the workshops at the IMI Open Info Day. Participants will be able to ask questions in a chat box.
Open Info Day presentations online
The topics of the 3rd Call and general aspects of participating in IMI projects have been explained during the Open Info Day on 22 October 2010 in Brussels.
Find 3rd Call partners
IMI has launched a new Partner Search Tool for people interested in the 3rd Call for proposals:
- search the partner database
- make your expertise known
- indicate topic of interest
2nd Call update
The selection procedure of Stage 1 and the evaluation procedure of Stage 2 are finalised, and the negotiation process has started. The Full Project Consortia (selected Applicant Consortia + EFPIA Consortia) have been invited to update the Full Project Proposal in the IMI electronic submission tool. Detailed instructions have been provided by email to the Coordinators and the Managing Entities. More info.
News from the IMI projects
PharmaTrain is launching new and upgraded Europe-wide Education and Training programmes on Integrated Drug Development Sciences in Autumn 2010. The programme includes Base courses and Master programmes taught at partner universities all across Europe. A full overview is available at www.pharmatrain.eu.
Another early achievement of the PharmaTrain project is the publication of a 2010 European Training Syllabus for Pharmaceutical Medicine on the PharmaTrain website. It summarises the learning content that will be addressed in the courses mentioned above. The syllabus has been internationally recognised and adopted by the International Federation of Associations of Pharmaceutical Physicians (IFAPP) and the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom. In Spring 2011, the corresponding detailed learning outcomes will be published in the 'PharmaTrain Programme Handbook. Shared Curriculum and best practices'.
The IMI project PharmaCog on Alzheimer's Disease has launched a new website.